A team of multiple myeloma experts review a patient profile, offering preliminary insights and underscoring the importance of advanced practice providers in optimizing patient care.
Stay up to date on recent advances in oncology nursing and patient care.
What Are the Barriers to CAR T-Cell Therapy Access in Multiple Myeloma?
Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies
July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More
Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape
SUD, Remote Monitoring Appear Feasible for Outpatient BiTE in MM
Linvoseltamab Gains FDA Accelerated Approval In R/R Myeloma
Personalized Cancer Vaccines: Watching For Immune-Related, Vaccine AEs
Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors
PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert
Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL